EndPoint Technologies and Envision Pharma Group unite to bring better technology to medical information
Mutual expertise in information technology will change the landscape of Medical Information.
November 28, 2017
Miramar Beach, FL USA – EndPoint Technologies, a specialty consulting firm focused on Medical Affairs in the life science industry, has announced it is now a division of Envision Pharma Group, a global technology and scientific communications company, with the goal of expanding their strategy, privacy, validation, and other consulting services into a much larger part of the pharmaceutical world.
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. EndPoint brings to Envision expertise around data privacy compliance and validation protocols, as well as far-reaching experience in the recognition, development, and introduction of emerging technologies critical to industry growth.
Within Envision Pharma Group, Endpoint Technologies will continue to operate as an independent entity. Joe Pierce, founder and CEO of EndPoint Technologies, says, “Envision Pharma Group is an excellent fit, particularly as it is realigning its technology and services around medical evidence and content with its iEnvision platform—in what we believe is the right long-term direction—and one which could revolutionize the way many companies manage medical evidence generation and communications in the future.”
Joe Brown, President of Envision Technology Solutions, commented, “We are very pleased to welcome Joe Pierce and the EndPoint team to the Envision family. EndPoint’s services will expand our capability in several key areas, such as RFP management, global privacy, validation support, consulting within the growing medical information area, and domain analytics. Their services will complement our iEnvision platform and product suite, and augment our customer support and operational excellence teams.”
EndPoint adds expertise, innovations, and partnerships surrounding artificial intelligence and self-service to Envision’s vast experience in global medical information and leadership on new technologies. Through this partnership, the Medical Affairs industry will see an acceleration in the development of solutions enabled by the iEnvision platform that will greatly improve efficiency, ease of use, and integration across multiple evidence-related departments within the global companies that both EndPoint and Envision serve.
About EndPoint Technologies: EndPoint Technologies is dedicated to providing comprehensive technology and business consulting services to life science organizations. Specializing in Medical Affairs in pharmaceutical and biotech companies, EndPoint provides insight and assistance with the process of selecting and implementing new technology, especially solutions related to data privacy. EndPoint also provides systems management, maintenance and support on a number of widely used software solutions. For more information on EndPoint Technologies, visit:
www.EndPointtech.com.
About Envision Pharma Group: Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence communication services and industry-leading technology solutions that have applicability across many areas of Medical Affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 80 companies, including 19 of the top 20 pharmaceutical companies.
Envision has thirteen offices: four in the United Kingdom – Horsham, Wilmslow, Marlow, and London; one in Serbia – Subotica; six in the United States – Philadelphia, PA, Southport, CT, Madison, NJ, Stirling, NJ, Glastonbury, CT, and New York, NY; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs 600 team members, including more than 200 highly qualified and experienced in-house medical writers and more than 100 technology solutions team members who provide software development and customer support.
https://www.envisionpharmagroup.com/
CONTACT INFORMATION:
EndPoint Technologies
Joe Pierce
President and CEO
Phone: 630-204-2652
Email: joe.pierce@EndPointtech.com
www.envisionpharmagroup.com
Envision Pharma Group
Gary Page
Head of Commercial, Envision Technology Solutions
Phone: +44 (0) 7976-686-669
Email: gary.page@EnvisionPharmaGroup.com
www.envisionpharmagroup.com
